Human mesenchymal stem cells support megakaryocyte and pro-platelet formation from CD34+ hematopoietic progenitor cells

Journal of Cellular Physiology

Volumn 184, Issue 1, 2000, Pages 58-69

  Cheng, Linzhao ^a,b   Qasba, Pankaj ^a,c   Vanguri, Padmavathy ^a   Thiede, Mark A ^a,d  

^a OSIRIS THERAPEUTICS INC   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^d Discovery Pharmacology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN;

ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL FUNCTION; CELL STIMULATION; CONTROLLED STUDY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MEGAKARYOCYTE; MEGAKARYOPOIESIS; MESENCHYME CELL; PRIORITY JOURNAL; STEM CELL; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE RELEASE REACTION; THROMBOCYTOPOIESIS;

ANTIGENS, CD; ANTIGENS, CD34; BLOOD PLATELETS; BONE MARROW CELLS; CELL ADHESION; CELL DIFFERENTIATION; CELLS, CULTURED; COCULTURE TECHNIQUES; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HUMANS; MEGAKARYOCYTES; MESODERM; PLATELET ACTIVATION; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; STEM CELLS; THROMBIN; THROMBOPOIETIN; TRANSCRIPTION, GENETIC;

EID: 0034038046     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4652(200007)184:1<58::AID-JCP6>3.0.CO;2-B     Document Type: Article

References (53)

1. Araneda M, Krishnan V, Hall K, Krishnan K. 1998. Serum thrombopoietin (TPO) levels in disorders of thrombocytopenia: implications for future use of recombinant TPO in clinical practice. Blood 92(Suppl):31a.
2. Avraham H, Vannier E, Cowley S, Jiang S, Chi S, Dinarello CA, Zsebo KM, Groopman JE. 1992. Effects of stem cell factor, c-kit ligand, on human megakaryocytic cells. Blood 79:365-371.
3. Bertolini F, Battaglia M, Pedrazzoli P, Da Prada GA, Lanza A, Soligo D, Caneva L, Sarina B, Murphy S, Thomas T, Robustelli della Cuna G. 1997. Megakaryocytic progenitors can be generated ex vivo and safely administered to autologous peripheral blood progenitor cell transplant recipients. Blood 89:2679-2688.
4. Beveridge R, Schuster M, Waller E, Stuart R, Abboud C, Cruickshank S, Menchaca D, Macri M, Connaghan DG. 1997. Randomized, double-blind, placebo-controlled trial of PEGylated recombinant human megakaryocyte growth and differentiation factor in breast cancer patients following autologous bone marrow transplantation. Blood 90(Suppl):580a.
5. Bruder SP, Horowitz MC, Mosca JD, Haynesworth SE. 1997. Monoclonal antibodies reactive with human osteogenic cell surface antigens. Bone 21:225-235.
6. Bruno E, Hoffman R. 1989. Effects of interleukin-6 on in vitro megakaryocytopoiesis: its interaction with other cytokines. Exp Hematol 17:1038-1043.
7. Bruno E, Miller ME, Hoffman R. 1989. Interacting cytokines regulate in vitro human megakaryocytopoiesis. Blood 76:671-677.
8. Bruno E, Briddell RA, Cooper RJ, Hoffman R. 1991. Effects of recombinant interleukin-11 on human megakaryocyte progenitor cells. Exp Hematol 19:378-381.
9. Bunting S, Widmer R, Lipari T, Rangell L, Steinmetz H, Carver-Moore K, Moore M, Keller G-A, de Sauvage FJ. 1997. Normal platelets and megakaryocytes are produced in vivo in the absence of thrombopoietin. Blood 90:3423-3429.
10. Burstein SA, Me R-L, Henthorn J, Friese P, Turner K. 1992. Leukemia inhibiting factor and interleukin-11 promote maturation of murine and human megakaryocytes in vitro. J Cell Physiol 153:305-312.
11. Caplan AI. 1991. Mesenchymal stem cells. J Ortho Res 9:641-650.
12. Cheng L, Mbalaviele G, Liu X, Novelli E, Vanguri P, Mosca J, Deans R, Civin CI, Thiede MA. 1998. Human mesenchymal stem cells support proliferation and multilineage differentiation of human hematopoietic stem cells. Blood 92(Suppl):57a (abstract 228).
13. Chirgwin JM, Pryzbyla AE, MacDonald RJ, Rutter WJ. 1979. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294-5299.
14. Choi E, Nichol J, Hokom M, Hornkohl A, Hunt P. 1995. Platelets generated in vitro from proplatelets displaying human megakaryocytes are functional. Blood 85:402-413.
15. Deryugina EI, Muller-Sieburg CE. 1993. Stromal cells in long-term cultures: keys to elucidation of hematopoietic development? Crit Rev Immunol 13:115-150.
16. Dorshkind K. 1990. Regulation of hematopoiesis by bone marrow stromal cells and their products. Annu Rev Immunol 8:111-137.
17. Du X, Williams DA. 1997. Interleukin-11: review of molecular, cell biology, and clinical use. Blood 89:3897-3908.
18. Eaves CJ, Cashman JD, Kay RJ, Dougherty GJ, Otsuka T, Gaboury LA, Hogge DE, Landsorp PM, Eaves AC, Humphries RK. 1991. Mechanisms that regulate the cell cycle status of very primitive hematopoietic cells in long term human bone marrow cultures. II: Analysis of positive and negative regulators produced by stromal cells within the adherent layer. Blood 78:110-117.
19. Ellis MH, Avraham H, Groopman JE. 1995. The regulation of megakaryocytopoiesis. Blood 9:1-6.
20. Gewirtz AM. 1995. Megakaryocytopoiesis: the state of the art. Thromb Haemost 74:204-209.
21. Guerriero A, Worford L, Holland HK, Guo GR, Sheehan K, Waller EK. 1997. Thrombopoietin is synthesized by bone marrow stromal cells. Blood 90:3444-3455.
22. Han ZC, Belucci S, Wan HY, Caen JP. 1992. New insights into the regulation of megakaryocytopoiesis by hematopoietic and flbroblast growth factors and transforming growth factor beta-1. Br J Haematol 81:1-5.
23. Hassan HT, Zander A. 1996. Thrombocytopenia after high-dose chemotherapy and autologous stem cell transplantation: an unresolved problem and possible approaches to resolve it. J Hematother 5:407-414.
24. Haynesworth SE, Baber MA, Caplan AI. 1992. Cell surface antigens on human marrow derived mesenchymal cells are detected by monoclonal antibodies. Bone 13:69-80.
25. Haynesworth SE, Baber MA, Caplan AI. 1996. Cytokine expression by human marrow-derived mesenchymal progenitor cells in vitro: effects of dexamethasone and IL1α. J Cell Physiol 166:585-592.
26. Hoffman R. 1989. Regulation of megakaryocytopoiesis. Blood 74:1196-1212.
27. Hogge H, Fanning SF, Bockhold K, Petzer A, Lambie K, Eaves A, Eaves CJ. 1997. Quantitation and characterization of human megakaryocyte colony forming cells using a standardized serum-free assay. Br J Haematol 96:790-800.
28. Ikebuchi K, Wong GG, Clark SC, Ihle JN, Hirai Y, Ogawa M. 1987. Interleukin-6 enhancement of interleukin-3 dependent proliferation of multipotential hematopoietic progenitors. Proc Natl Acad Sci USA 84:9035-9039.
29. Jaiswal N, Haynesworth SE, Caplan AI, Bruder SP. 1997. Osteogenic differentiation of purified culture expanded human mesenchymal stem cells in vitro. J Cell Biochem 64:295-312.
30. Johnstone B, Hering TM, Caplan AI, Goldberg VM, Yoo JU. 1998. In vitro chondrogenesis of bone marrow derived mesenchymal progenitor cells. Exp Cell Res 238:265-272.
31. Kaushansky K. 1995. Thrombopoietin: the primary regulator of platelet production. Blood 86:419-431.
32. Kaushansky K, O'Hara RJ, Berkner K, Segal GM, Hagen FS, Adamson JW. 1986. Genomic cloning, characterization and multilineage growth promoting activity of human granulocyte-macrophage colony stimulating factor. Proc Natl Acad Sci USA 83:3101-3105.
33. Kawashima I, Ohsumi J, Mita-Honjo K, Shimoda-Takano K, Ishikawa H, Sakakibara S, Miyadai K, Takiguchi Y. 1991. Molecular cloning of cDNA encoding adipogenesis inhibitory factor and identity with interleukin-11. FEBS Lett 283(2):199-202.
34. Keller JR, Bartelmez SH, Sitnicka E, Ruscetti FW, Ortiz M, Gooja JM, Jacobson SEW. 1994. Distinct and overlapping direct effects of macrophage inflammatory protein-lα and transforming growth factor-β on hematopoietic progenitors/stem cells growth. Blood 84:2175-2181.
35. Lazarus HM, Winton EF, Williams SF, Grinblatt D, Campion M, Cooper BW, Gunn H, Manfreda S, Isaacs RE. 1995a. Phase I multicenter trial of interleukin 6 therapy after autologous bone marrow transplantation in advanced breast cancer. Bone Marrow Transplant 15:935-942.
36. Lazarus HM, Haynesworth SE, Gerson SL, Rosenthal NS and Caplan AI. 1995b. Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): implications in therapeutic use. Bone Marrow Transplant 16:557-564.
37. + cells. Blood 92(Suppl):725a (abstract 2977).
38. Majumdar MK, Thiede MA, Mosca JD, Moorman M, Gerson SL. 1998. Phenotype and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells. J Cell Physiol 17:57-66.
39. Mbalaviele G, Jaiswal N, Meng A, Cheng L, van den Bos C, Thiede M. 1999. Human mesenchymal stem cells promote human osteoclast differentiation from CD34+ bone marrow hematopoietic progenitors. Endocrinology 140(8):3736-3743.
40. Mosca JD, Majumdar MK, Hardy WB, Pittenger MF, Thiede MA. 1996. Initial characterization of the phenotype of the human mesenchymal stem cells and their interaction with cells of the hematopoietic lineage. Blood 88(Suppl):186a.
41. Mossuz P, Schweitzer A, Molla A, Berthier R. 1997. Expression and function of receptors for extracellular cellular matrix molecules in the differentiation of human megakaryocytes in vitro. Br J Haematol 98:819-827.
42. + cells. Blood 91:830-843.
43. Paul SR, Yang YC, Donahue RE, Goldring S, Williams DA. 1991. Stromal cell-associated hematopoiesis: immortalization and characterization of a primate bone marrow-derived stromal cell line. Blood 77(8):1723-1733.
44. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, and Marshak DR. 1999. Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147.
45. Prockop DJ. 1997. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276:71-74.
46. Qian S, Fu F, Li W, Chen Q, de Sauvage FJ. 1998. Primary role of the liver in thrombopoietin production shown by tissue-specific knock-out. Blood 91:2189-2191.
47. Schiffer CA, Miller K, Larson RA, Stone R, Amrein P, Antin JH, Zani VJ. 1998. A double blind, placebo controlled trial evaluating PEGylated recombinant human megakaryocyte growth and differentiation factor (MGDF) as an adjunct to induction and consolidation therapy in patients with acute myeloid leukemia (AML). Blood 92(Suppl):313a.
48. Szilvassy SJ, Hoffman R. 1995. Enriched hematopoietic stem cells: basic biology and utility. Biol Blood Transplant 1:3-17.
49. Tepler, I, Elias, L, Smith JW III, Hussein M, Rosen G, Chang AY-C, Moore JO, Gordon MS, Kuca B, Beach KJ, Loewy JW, Garnick MB, Kaye JA. 1996. A randomized placebo-controlled trial of recombinant human interleukin 11 in cancer patients with severe thrombocytopenia due to chemotherapy. Blood 87:3607-3614.
50. Vadhan-Raj S, Verschraegen C, McGarry L, Bueso-Ramos C, Kudelka A, Freedman R, Edwards C, Bevers M, Levenback C, Gershenson D, Jones D, Yang T, Bast RC, Kavanagh J. 1997. Recombinant human thrombopoietin attenuates high-dose carboplatin-induced thrombocytopenia in patients with gynecologic malignancy. Blood 90(Suppl):580a.
51. Wakatani S, Saito T, Caplan AI. 1995. Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve 18:1417-1426.
52. Williams JL, Pipia GG, Datta NS, Long MW. 1998. Thrombopoietin requires additional megakaryocytic-active cytokines for optimal ex vivo expansion of megakaryocyte precursor cells. Blood 91:4118-4126.
53. Young RG, Butler DL, Weber W, Caplan AI, Gordon, SL, Fink DJ. 1998. The use of mesenchymal stem cells in a collagen matrix for achilles tendon repair. J Orthop Res 16:406-413.